Eli Lilly and Company (NYSE:LLY) on Monday announced the appointment of Lucas Montarce as executive vice president and chief financial officer and member of the company’s Executive Committee, effective immediately.
Montarce has been with Lilly since 2001, holding various finance leadership roles, including:
- Group Vice President, Corporate Controller, and CFO of Lilly Research Laboratories
- Vice President, Finance, and CFO of Lilly International
- Vice President, Finance, and Global CFO of Elanco Health
Most recently, Montarce served as President and General Manager for the Spain, Portugal, and Greece hub.
David A. Ricks, chair and CEO commented, “Developing leadership talent has always been a strength for Lilly, and Lucas has thrived in a wide variety of roles of increasing scope and impact. Having worked directly with Lucas for more than a decade, I am highly confident he has the drive, curiosity, and integrity to excel as our next CFO.”